LMR Partners’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-24,274
Closed -$102K 566
2018
Q3
$102K Sell
24,274
-30,265
-55% -$127K 0.01% 325
2018
Q2
$211K Buy
+54,539
New +$211K 0.01% 406